The need for high-throughput approaches in absorption, distribution, metabo
lism and excretion studies is driven by the impact of high-speed chemistry
and pharmacological screening. Perhaps an even greater impact is that these
studies will, in the future, provide large data sets that can be used to p
redict biological events related to absorption, bioavailability and metabol
ism of drugs. Through linking of in silico and in vitro methods, considerab
le progress has recently been made towards this future perspective. Despite
this progress, these approaches do not yet replace in vivo methods.